AlloVir (ALVR) Stock Chart & Stock Price History $2.57 +0.15 (+6.20%) As of 07/22/2025 Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AlloVir Stock Price Performance The AlloVir (ALVR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 85.10%, with a year-to-date return of -73.40%. In the past month, the stock has increased 8.90%, reflecting recent market activity. As of the latest close, AlloVir traded at $2.57 with a market cap of $12.96 million and volume of 148,226 shares. Receive ALVR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+6.20%1 Month Performance+8.90%3 Month Performance-63.34%Year-To-Date Performance-73.40%1 Year Performance-85.10% ALVR Stock Chart for Thursday, July, 24, 2025 ALVR Chart by TradingView AlloVir Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/23/2025$2.39$2.57+7.53%$2.59$2.41148,226 shs$12.96 million07/22/2025$2.39$2.39$2.54$2.3740,606 shs$12.05 million07/21/2025$2.39$2.39$2.54$2.3740,606 shs$12.05 million07/18/2025$2.46$2.42-1.63%$2.52$2.35203,569 shs$12.20 million07/17/2025$2.40$2.46+2.50%$2.59$2.4036,951 shs$12.41 million07/16/2025$2.61$2.40-8.05%$2.60$2.3363,448 shs$12.10 million07/15/2025$2.43$2.61+7.41%$2.62$2.4633,885 shs$13.16 million07/14/2025$2.43$2.43$2.65$2.4268,547 shs$12.25 million07/11/2025$2.55$2.50-1.96%$2.64$2.4024,666 shs$12.61 million07/10/2025$2.58$2.55-1.16%$2.64$2.3665,226 shs$12.86 million Get the Latest News and Ratings for ALVR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. 07/09/2025$2.61$2.58-1.15%$2.64$2.5511,765 shs$13.01 million07/08/2025$2.50$2.61+4.40%$2.61$2.4014,700 shs$13.16 million07/07/2025$2.50$2.50$2.69$2.5035,701 shs$12.61 million07/04/2025$2.56$2.50-2.34%$2.69$2.5035,701 shs$12.61 million07/03/2025$2.58$2.56-0.78%$2.75$2.5615,106 shs$12.91 million07/02/2025$2.67$2.58-3.37%$2.73$2.572,793 shs$13.01 million07/01/2025$2.62$2.67+1.91%$2.72$2.625,727 shs$13.47 million06/30/2025$2.62$2.62$2.70$2.5438,347 shs$13.21 million06/27/2025$2.60$2.56-1.54%$2.67$2.4728,297 shs$12.91 million06/26/2025$2.49$2.60+4.42%$2.65$2.2828,792 shs$13.11 million06/25/2025$2.36$2.49+5.51%$2.67$2.3772,501 shs$12.56 million06/24/2025$2.40$2.36-1.67%$2.53$2.3514,675 shs$11.90 million06/23/2025$2.40$2.40$2.75$2.32150,164 shs$12.10 million Related Companies EGRX Stock Price Chart GANX Stock Price Chart RNXT Stock Price Chart OSTX Stock Price Chart GRCE Stock Price Chart NBRV Stock Price Chart PRLD Stock Price Chart ELYM Stock Price Chart KLRS Stock Price Chart AADI Stock Price Chart Receive ALVR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for AlloVir and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALVR) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AlloVir, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AlloVir With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
